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We devised an approach to extract control principles of cellular bioenergetics for intact and
impaired mitochondria from ODE-based models and applied it to a recently established
bioenergetic model of cancer cells. The approach used two methods for varying ODE model
parameters to determine those model components that, either alone or in combination with other
components, most decisively regulated bioenergetic state variables. We found that, while
polarisation of the mitochondrial membrane potential (DCm) and, therefore, the protomotive
force were critically determined by respiratory complex I activity in healthy mitochondria,
complex III activity was dominant for DCm during conditions of cytochrome-c deficiency. As a
further important result, cellular bioenergetics in healthy, ATP-producing mitochondria was
regulated by three parameter clusters that describe (1) mitochondrial respiration, (2) ATP
production and consumption and (3) coupling of ATP-production and respiration. These
parameter clusters resembled metabolic blocks and their intermediaries from top-down control
analyses. However, parameter clusters changed significantly when cells changed from low to high
ATP levels or when mitochondria were considered to be impaired by loss of cytochrome-c. This
change suggests that the assumption of static metabolic blocks by conventional top-down control
analyses is not valid under these conditions. Our approach is complementary to both ODE and
top-down control analysis approaches and allows a better insight into cellular bioenergetics and
its pathological alterations.
Introduction
Studying the mechanisms of cellular bioenergetics is essential
to better understand cellular physiology and pathology. During
the last century, several experimental and theoretical approaches
provided a detailed picture of the basic physiological mechanisms
of cellular ATP production and consumption.1,2 More
recently, the importance of cellular bioenergetic deregulations
in several pathologies has become apparent. In cancer, cellular
bioenergetics are altered to favour glycolysis over mitochondrial
ATP production, making cancer cells better suited to cope
with hypoxic conditions in solid tumours,3 and likely more
resistant to therapeutically induced bioenergetic crises.4–8 In
neurodegenerative diseases and ischemic stroke, alterations
to the mitochondrial respiratory chain or impairment of
mitochondrial ATP production are important hallmarks of
the respective pathogeneses.9–11
Several approaches are available for studying cellular bio-
energetics. Top-down control analyses12 assume metabolic
blocks (such as glycolysis, cytosolic ATP consumption,
mitochondrial respiration and oxidative phosphorylation)
and describe how these metabolic blocks interact by inter-
mediary fluxes such as metabolite fluxes (ATP, NADH fluxes).
Top-down control analyses abstract details of the underlying
molecular mechanisms, and are therefore well suited to the
study of large-scale networks such as mitochondrial and
cytosolic ATP production/consumption.12–15 These approaches,
however, are confined to near steady-state fluxes and may not be
correct when fluxes are not in steady state equilibrium or when
conditions change between mitochondria that produce ATP and
those in a resting state. Likewise, the definitions of the metabolic
blocks and their interactions may be arbitrary. While metabolic
blocks are derived from bioenergetics in healthy physiology, it is
not clear whether these blocks resemble cellular energetics in a
pathological state such as when mitochondria are impaired.
In contrast, mechanistic approaches based on ordinary
differential equations (ODEs) integrate the detailed bio-
physical interplay of cellular and mitochondrial components
such as respiratory complexes, molecular transporters, meta-
bolites, ions and enzyme reactions.16–19 As they are based on
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molecular mechanisms, they are well suited to the study of a
broad range of physiological and pathological situations, and
the transition between these states. They also allow the study
of components and behaviour under conditions far from
energetic equilibrium, as a function of time. As a drawback,
the high level of detail of these models often occludes how
bioenergetic components act together on a larger scale.
Abstraction of concepts is necessary to build large-scale bio-
energetic models that not only model mitochondrial and cytosolic
ATP production, but also integrate signalling processes recently
associated to cellular bioenergetic pathological alterations.6,20
We present here an approach that abstracts regulatory
principles from ODE-based models of cellular bioenergetics,
and is flexible enough to be applied to situations where cellular
bioenergetics change dramatically. We exemplify our approach
by applying it to a model of mitochondrial bioenergetics16 that
we have recently calibrated to resemble bioenergetic data from
in house, single-cell microscopy experiments17 in HeLa cervical
cancer cells. Our study is the first to demonstrate that ad hoc
assumptions of (top-down) metabolic control analyses, such as
the assumption of three independent bioenergetic clusters, are
justified by (bottom up) mechanistic principles, yet these
clusters need to be adapted when energy levels or physiological
conditions change to pathological situations. The study design
and a result summary are given in Fig. 1.
Materials and methods
Model of mitochondrial bioenergetics
We employed a model of the mitochondrial respiration chain
and ATP production established by Beard which built upon
works by Korzeniewski et al.16,18,19,21,22 We recently extended
and calibrated the model to include parameters characterised
in isolated mitochondria and successfully applied it to study
mitochondrial bioenergetic recovery in HeLa cells following
mitochondrial outer membrane permeabilisation.17 The model
studies a set of bioenergetic state variables (Table 1) in the
mitochondrial matrix (4.5% of total cell volume), mitochondrial
inter-membrane space (0.5% of total cell volume), and in the
cytosol (95% of total cell volume). State variable changes were
mediated by bioenergetic flux combinations (Table 1, fourth
column and Table 2) and described by a set of ordinary
differential equations (ODEs). The mitochondrial tricarboxylic
acid (TCA) cycle was not modelled explicitly. Instead, a sub-
strate dehydrogenation process (NAD+H+-NADH+) was
assumed to be present that drives the respiratory chain by
supplying NADH. According to ref. 16, this process was
modelled by an input flux
JDH ¼ XDHðrxNADx NADHÞ  1þ Pix
kPi1
 
 1þ Pix
kPi2
 
ð1Þ
which drives mitochondrial respiration by providing NADH.
The constant rx was set to 45.9 in order to establish JDH by
generating a NADH/NAD disequilibrium. The explicit depen-
dency of JDH on ionic phosphate Pi in the matrix (index x) was
also taken from ref. 16 where it was introduced to resemble
measurements of isolated mitochondria under varying phosphate
buffer conditions. NADH produced by the flux in eqn (1) was
modelled to be subsequently consumed by complex I.
Complex I activity drove complex III activity which in turn
drove complex IV activity (Table 2, components 2, 3 and 4).
Each complex was assumed to pump protons from the matrix
into the mitochondrial inter membrane space (4, 4 and 2
protons for complexes I, III and IV, respectively). This
established a proton gradient for ATP synthase. ATP synthase
was modelled to synthesise ATP from ADP and phosphate,
and to require Mg2+ as a co-factor (defined together as
component 5). ATP was provided by the adenosine nucleotide
transferase (ANT, component 6). Constitutive proton leaks
(component 7) were present as required for respiration in
the absence of ATP production. The outer membrane was
considered permeable for ADP, ATP, phosphate and protons
(component 8). Phosphate/proton and potassium/proton
Fig. 1 Study design and key findings. The strategy followed to identify
bioenergetic regulation principles in HeLa cells under different condi-
tions is depicted and key findings of this study are highlighted. Building
on the recently calibrated bioenergetic ODE model of Beard,16,17 we
utilised two different methods of parameter variation to extract
regulatory principles of cellular bioenergetics. Both methods were
applied to cells with intact state-3 and state-4 mitochondria (‘physio-
logical conditions’) and to cells whose mitochondria were depleted of
cytochrome-c (cyt-c). The respective figures where results are discussed
are also highlighted (MCA—Metabolic Control Analysis).
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exchangers (components 9 and 10) were considered to maintain
ionic equilibrium and to provide phosphate for respiration.
Cytosolic ATP levels were assumed to vary over time and were
determined by mitochondrial ATP production (component 5)
and by cytosolic ATP processes. The latter processes included
cytosolic ATP production (i.e. by glycolysis) and ATP con-
sumption (such as Na+/K+-ATPase activity and protein
production). This separate treatment accounts for independent
changes in the glycolytic rate, which may be caused by
oncogenic signalling,17,23,24 and for changes in ATP consumption
which may, for instance, result from a cellular signalling response
to low energy.25 Cytosolic ATP production was modelled to
increase ATP concentration in proportion to the amount of
available ADP (ADP- ATP, flux Jprod B ADP). The speed
of ATP consuming processes was assumed to be proportional
to the levels of available ATP (ATP- ADP, Jcons B ATP).
Table 1 Bioenergetic state variables, their initial values and temporal changes used in the ODE model: the first and second columns provide the
symbol and description of the bioenergetic state variables employed in the ODEmodel. The third column gives the initial concentration used in the
calculations. The fourth column describes their temporal changes based on bioenergetic fluxes (Table 2) and on parameters in Tables 4 and 5.
These temporal changes constitute the ODE system. Indices x, i and c of state variables and metabolites indicate mitochondrial matrix, inter-
membrane space and cytosol, respectively
Symbol Description Initial conc./mM
ODE equation
Temporal change: d[symbol]/dt = . . .
Hx Matrix protons 10
5 (pH = 8) XbuffHx(JDH  (4 + 1)JC1  (4  2)JC3  (2 + 2)JC4 + (nA  1)JF1
+ 2JPi1 + JHle  JKH)/Wx
Kx Matrix potassium 50 (JKH + JK)/Wx
Mg2+x Matrix magnesium 1 (JMgATPx  JMgADPx)/Wx
NADH2x Matrix NADH 1.5 (+JDH  JC1)/Wx
QH2
2
x Matrix ubiquinone 0.8 (JC1  JC3)/Wx
cytCox Oxidised cyt-c (IMS) 1.5 (2JC3  2JC4)/Wi
cytCred Reduced cyt-c (IMS) 1.2 Calculated from total cyt-c
ATPx Matrix free ATP 3 : 1 or 100 : 1 (+JF1  JANT)/Wx
ADPx Matrix free ADP 1 : 3 or 1 : 100 (JF1 + JANT)/Wx
ATPmx Matrix Mg
2+-bound ATP 0 (JMgATPx)/Wx
ADPmx Matrix Mg
2+-bound ADP 0 (JMgADPx)/Wx
Pix Matrix phosphate (phosphate ions) 10 (JF1 + JPiHt)/Wx
ATPi IMS free ATP 0 (+JATP + JANT + JAKi)/Wi
ADPi IMS free ADP 0 (+JADP  JANT  2JAKi)/Wi
ATPmi IMS Mg
2+-bound ATP 0 (JMgATPi)/Wi
ADPmi IMS Mg
2+-bound ADP 0 (JMgADPi)/Wi
Pii IMS phosphate (phosphate ions) 10 (JPiHt + JPi2)/Wi
DCm Mitochondrial membrane potential 150 (4JC1 + 2JC3 + 4JC4  nAJF1  JANT  JHle  JK)/Cim
Hi IMS protons 10
5 (pH = 8) (JDH + (4 + 1)JC1 + (4  2)JC3 + (2 + 2)JC4  (nA  1)JF1
 2JPi1  JHle + JKH + JHt)/Wi
ATPc Cytosolic ATP 3 : 1 or 100 : 1 (JATP  JATPC)/Wc
ADPc Cytosolic ADP 1 : 3 or 1 : 100 (JADP + JATPC)/Wc
Table 2 Model components and their bioenergetic fluxes in the ODE’s: mathematical forms of the bioenergetic fluxes that mediate state variable
changes in Table 1. The first column contains model component numbers assigned to bioenergetic fluxes (components numbered in Fig. 2). The
second column describes the flux and the flux symbol used in Table 1. The third column contains the mathematical formula defining the flux.
Fluxes depend on state variables (Table 1), model parameters (Table 3) and biophysical constraints (Table 4). All flux biophysical details can be
found in ref. 16
# Flux Flux equation for ODE (Table 1)
(1) Input flux NAD (dehydrogenase flux) JDH = XDH(rx  NADx  NADHx){(1 + Pix/kPi1)/(1 + Pix/kPi2)}
(2) Respiratory complex I JC1 = XC1(exp((dGC1op + 4dGH)/RT)NADHxQ  NADxQH2)
(3) Respiratory complex III JC3 = XC3((1 + Pix/kPi3)/(1 + Pix/kPi4)){exp((dGC3op + 4dGH2FDCm)/
(2RT))CoxQH2
0.5  cytCredQ0.5}
(4) Respiratory complex IV JC4 = XC4(O2,x/(O2,x + kO2))(cytCred/cytCtot){exp((dGC4op
+ 2dGH)/(2RT))cytCred(O2,x
0.25)  cytCoxexp(FDCm/RT)}
(5) ATP synthase (FoF1) JF1 = XF1(exp((dGF1op  nAdGH)/RT)(KDD/KDT)ADPmx  Pix  ATPmx
(5) Binding of Mg2+ to matrix ATP JMgATPx = XMgA(ATPfx  Mgx  KDT  ATPmx)
(5) Binding of Mg2+ to inner membrane ATP JMgATPi = XMgA(ATPfi  Mgi  KDT  ATPmi)
(5) Binding of Mg2+ to matrix ADP JMgADPx = XMgA(ADPfx  Mgx  KDD  ADPmx)
(5) Binding of Mg2+ to inner membrane ADP JMgADPi = XMgA(ADPfi  Mgi  KDD  ADPmi)
(6) Adenosine nucleotide transferase (ANT) JANT = XANT(ADPfi/(ADPfi + ATPfiexp(FDCi/RT))
 ADPfx/(ADPfx + ATPfxexp(FDCx/RT)))(ADPfi/(ADPfi + kmADP))
(7) Proton leaks JHle = XHleDCm(Hiexp(FDCm/RT)  Hx)/(exp(FDCm/RT)  1)
(8) ADP MOM permeability JADP = gXA(ADPc  ADPi)
(8) ATP MOM permeability JATP = gXA(ATPc  ATPi)
(8) Phosphate MOM permeability JPi2 = gXPi2(Pic  Pii)
(8) Proton MOM permeability JHt = gXHT(Hi  Hx)
(9) Phosphate/proton JPi1 = XPi1(Hx  H2PIi  Hi  H2PIx)/(H2PIi + kdHPi)
(10) Potassium/hydrogen JKH = XKH(Ki  Hx  Kx  Hi)
(11) Cytosolic ATP processes JATPC = xATPK(ATPe  KADTP  ADPe)
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Superposition of both effects leads to a flux
JATPC = Jprod  Jcons = xATPC(KATPC ADP  ATP). (2)
The free parameters KATDP and xATDP were adapted such that
the flux in eqn (2) together with mitochondrial ATP production
(component 5) renders a constant cytosolic ATP : ADP ratio
of 100 : 1 or of 3 : 1, assuming energetically saturated HeLa
cells26 or cells with reduced levels of ATP (KATDP = 30 or 2,
xATDP = 0.0054 or 1.1, for an ATP : ADP ratio of 100 : 1 and
3.1, respectively). We remark that according to the above
assumptions mitochondrial ATP production alone would
replenish ATP levels in intact mitochondria, while eqn (2)
drives the ATP : ADP ratio to a lower equilibrium. As a
consequence, the cytosolic processes modelled in eqn (2) always
lead to a net consumption of mitochondrially generated ATP
in cells with intact mitochondria. Likewise, since mitochondria
still produce ATP when their cyt-c is depleted to 5%, eqn (2)
also describes a net consumption of mitochondrial ATP in such
a case. Cytosolic ATP processes were therefore denoted as
‘cytosolic ATP consumption’ to better emphasise their ATP
consuming role in these cases. Only in the case of cyt-c
depletion to 0.5%, where no ATP is produced by mitochondria,
do we retain the term ‘cytosolic ATP processes’ (for details on
mitochondrial ATP production in all these cases see ref. 17).
ATP and ADP levels in the other compartments (the mito-
chondrial matrix and inter membrane space) were established
by a diffusion equilibrium with the external compartment.
Consistent with ref. 16, AMP was not studied explicitly.
Cytosolic pH was assumed to be 7.4 to resemble cells in
HEPES buffer. Matrix pH was set to 8.0 to resemble the
pH-gradient between matrix and cytosol as detected by single
cell imaging using pH dependent fluorescent proteins.2,27
Cyt-c depletion was modelled as a consequence of cyt-c release
following mitochondrial outer membrane permeabilisation
(MOMP); a condition occurring during cellular injury and
during chemotherapeutic treatment.28 Due to the subsequent
re-equilibration of cyt-c between the cytosol and the mito-
chondrial inter-membrane space a remnant fraction of cyt-c in
the inter-membrane space is considered and two scenarios are
assumed. In the first scenario, a tiny fraction of 0.5% cyt-c was
assumed to remain in the mitochondrial inter-membrane
space. This is consistent with the assumption that (i) cyt-c
release leads to a complete re-equilibration between the mito-
chondrial inter-membrane space (10% of mitochondrial volume)
and the cytosol, and (ii) the volume fraction of mitochondria in
cancer cells is low (5% was assumed), consistent with previous
measurements by our group using z-stack confocal imaging and
TMRM as a mitochondrial marker in several cell lines.29–31 In
the second scenario a more modest depletion of cyt-c with 5%
cyt-c remaining in the inter-membrane space was investigated.
This depletion modelled incomplete cyt-c release due to impaired
mitochondrial cristae remodelling,32–34 leaving a higher amount
of cyt-c in the inter-membrane space. Alternatively, this situation
resembled a situation where cells, such as cardiac muscle cells,
have higher fractions of mitochondria (20%) resulting in higher
cyt-c levels after re-equilibration between the mitochondrial inter
membrane space and the cytosol compared to cells with a lower
mitochondrial fraction.
The model code was implemented in MATLAB (The
Mathworks, UK) and is provided as ESI 2.w
Model structure
In an attempt to simplify the model layout, we defined model
parameters, fluxes, components and state variables in a hierar-
chical manner. The lowest level of regulation was given by model
parameters (Table 3). These parameters defined the bioenergetic
fluxes (Table 2) which were grouped into model components
(Table 2, first column and Fig. 2, (1)–(11)). As parameters are
mathematically related to the fluxes defining these components,
the influence of each parameter on these components is also
defined, and is listed in Table 3 (2nd column). Text colour coding
in Fig. 2 also indicates whether parameter increases lead to an
increase or decrease in component activity. In certain cases, one
parameter influenced two components and, conveniently, the
direction of influence of this parameter on both components was
always the same. Additionally, several parameters can influence
the same component, as seen in Fig. 2. Finally, bioenergetic state
variables are influenced by defined fluxes (Table 1). The bio-
energetic state is defined as the entire set of bioenergetic state
variables of Table 1 and quantified as below (eqn (3)).
Extracting regulation principles of intact and impaired mitochondria
Two methods were used to extract regulation principles of cellular
bioenergetics from the mechanistic details of the model. Both
methods studied how variations of the 31 parameters influenced
either a bioenergetic state variable or the bioenergetic state as a
whole. We assumed four biological situations in our analysis—
(1) intact ATP producing mitochondria (ATP : ADP = 3 : 1),
(2) intact mitochondria under energy saturation (ATP : ADP =
100 : 1), (3) impairedmitochondria following complete (99.5%) or
(4) incomplete (95%) cytochrome-c release (the last two situations
resulted in 70% and 67% ATP assuming the same ATP con-
sumption as in (2) and considering mitochondrial impairment).
In the first method (single parameter variation) each parameter
was varied by a factor, 10, 5, 0.2 or 0.1, equivalent to a ten- or
five-fold up- or down-regulation. The fixed relationships
between parameters and components allowed us to study
how individual components influenced a bioenergetic state
variable such as DCm (Table 1).
A second method (parameter cluster analysis) analysed the
influence of multiple parameter changes on the entire bio-
energetic state. This method aims to identify parameter com-
binations (‘clusters’) that have the greatest influence on the
bioenergetic state. We therefore varied parameters in combi-
nations, assessed the influence of these parameters on the
bioenergetic state, performed a principal component analysis
of the resulting data matrix, selected the most important
principal components and grouped parameters within each
component according to their origin (whether they come
from respiration complexes and metabolites, ATP production,
cytosolic ATP processes or from other sources).
This method is an adaptation of the sloppy parameter
analysis of ref. 35 in which co-variation of model parameters
and the effect of these variations on model output was studied.
We assumed the bioenergetic state to be represented by a state
vector
-
s(
-
p0) = hsi(p0j)i that comprised all modelled bioenergetic
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state variables under equilibrium conditions given in Table 1.
This state vector was calculated by a set of model parameters
-
p0 = hp0ji and changes of state variables si were investigated
when model parameters changed from a reference scenario
-
p0
to a scenario characterised by parameter vector
-
p. This change
is quantified by defining the least square function
w2ð~p0Þ ¼
X
i
sið~p0Þ  sið~p0Þ
sið~p0Þ
 2
; ð3Þ
which summarises the relative changes of all state variables
-
s(
-
p0) = hsi(p0j)i--s(-p) = hsi(pj)i in the model that occur upon
parameter alterations
-
p0-
-
p = hpji. All state variables si are
normalised to their value at the reference scenario si(
-
p0).
For small parameter changes (
-
p =
-
p0 + D-p with D-p small),
w2(-p) can be approximated by a Taylor expansion at the
parameter value
-
p0,
w2ð~pÞ ¼ w2ð~p0Þ þ
X
i
@w2ð~p0Þ
@pi
ðpi  p 0i Þ
þ
X
i
X
j
@2w2ð~p0Þ
@pi@pj
ðpi  p 0i Þðpj  p 0j Þ þ   
ð4Þ
Taking into account that w2(-p0) = 0 and noting that the
positive definiteness of w2(-p0) leads to a vanishing first derivative,
the second derivative remains the leading term. We therefore
analysed the Hessian matrix with components
Hij ¼ @
2w2ð~p0Þ
@pi@pj
ð5Þ
with respect to changes of the model parameters pi. To
consider relative parameter changes, we replaced qpi by
the logarithmic derivatives and defined the normalised state
variable %si(
-
p) = si(
-
p)/si(
-
p0).
Inserting eqn (1) into eqn (3), we obtained
Hijð~p0Þ ¼ @s
0
i ð~p0Þ
@ logðpiÞ
@s0i ð~p0Þ
@ logðpjÞ ; ð6Þ
which is the outer product of the two logarithmic derivatives
of the normalised state vector %si(
-
p) evaluated at
-
p0. Since
we evaluated Hi,j at
-
p0, the second derivative vanished.35
The Hessian matrix (eqn (3)) was evaluated numerically
via finite differences derivatives. The principal component
analysis of eqn (6) was performed using the MATLAB
routine pcacov.
Table 3 Model parameters used in the ODE’s, their influence on model components and their standard values: model parameters are listed whose
variations are discussed in the paper. The first column provides the parameter reference number that was used throughout the text and figures. The
second column refers to component numbers, given in Table 2 and Fig. 2, and whether the component is positively (+) or negatively () influenced
by this parameter (direct or indirect proportional relation of the parameter to the component as seen from Table 2). The name, description, value
and units of the parameters are also given
# Regulates Symbol Name used in the text (explanation) Value Units
1 (+2) NADtot Total NAD(H) 0.242
c mM
2 (+3), (+4) cytCtot Total cyt-c. 2.7
a mM
3 (+2), (+3) Q Total ubiquinone 1.35a mM
4 (+4), (+5) Atot Total adenosine phosphate (ATP + ADP + AMP) 4.86
d mM
5 (1) kPi1 Input 1 (phosphate dependency) 0.13413a mM
6 (1) kPi2 Input 2 (phosphate dependency) 0.67668a mM
7 (+1) XDH Input 3 (flux activity) 0.09183
a mol s1 M1 (l mito vol)1
8 (+1) r Input 4 (NADH/NAD ratio) 45.807d Unitless
9 (+2) XC1 Complex I activity 1.02  10+3 d mol s1 M1 (l mito vol)1
10 (+3) XC3 Complex III activity 0.2241
d mol s1 M1 (l mito vol)1
11 (3) kPi3 Complex III parameter 1 (phosphate dependency) 0.19172a mM
12 (3) kPi4 Complex III parameter 2 (phosphate dependency) 25.31a mM
13 (+4) XC4 Complex IV activity 3.2  104 d mol s1 M1 (l mito vol)1
14 (+4) kO2 Complex IV parameter (oxygen saturation) 1.2  104 d M
15 (+5) XF1 ATP synthase activity 6.83  10+3 d mol s1 M2 (l mito vol)1
16 (+11)g xATPK ATP consumption kinetics 1.1,
e 0.0540f min1
17 (11)g KATPK ATP consumption equilibrium ATP : ADP 2,e 30f Unitless
18 (+5), (+6) XMgA Mg
2+ concentration 20b mM
19 (+6) XANT ANT activity 2  103 a mol s1 (l mito vol)1
20 (+6) km,ADP ANT parameter 1 (Michaelis–Menten) 3.5  106 b M
21 (+7) XHle Proton leak activity 150
a mol s1 M1 (l mito vol)1
22 (+8) XHt Mito outer membrane (MOM) proton permeability 20
a mm s1
23 (+8) g Mito outer membrane (MOM) area 5.99a mm1
24 (+8) XA Mito outer membrane (MOM) nucleotide permeability 327
a mm s1
25 (+8) XPi2 Mito outer membrane (MOM) phosphate permeability to 85
a mm s1
26 (9) kdHPi H+/Phos parameter 1 (proton–phosphate binding) 1  106.75 a M
27 (9) kPIH H+/Phos par. 2 (proton–phosphate dissociation) constant 4.5  104 a M
28 (+9) XPi1 H
+/Phos activity 3.3943  10+5 mol s1 M1 (l mito vol)1
29 (+10) XKH K
+/H+ activity (potassium–proton antiport) 2.9802  10+7 mol s1 M2 (l mito vol)1
30 —h Xbuff Matrix hydrogen buffer 100
a M1
31 —h Cim Mito capacitance 6.76  106 a mol1 (l mito vol)1 mV
a Values were taken from ref. 21. b Values were taken from ref. 2. c Values were taken from ref. 29. d Values were taken from ref. 17. e Values were
fitted to match an ATP : ADP ratio of 3 : 1 (state 3). f Values were fitted to match an ATP : ADP ratio of 100 : 1 (state 4). g KATPK is assumed to
be lower than the actual ATP : ADP ratio leading to cytosolic consumption of ATP. The lower the KATPK, the higher the consumption.
h These
model parameters are not associated to a component, but are general parameters used in the model.
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Results
A structured approach to the investigation of bioenergetic
regulation in intact and impaired mitochondria
To study cellular and mitochondrial bioenergetics under physio-
logical and pathological conditions, we built upon a model
proposed by Beard16 that is partly based on earlier work by
Korzeniewski et al.36–39 Their model investigated ion and
metabolite changes in three compartments: the mitochondrial
matrix, the mitochondrial inter membrane space and the
cytosol. It allowed us to study the influence of these changes
on the mitochondrial membrane potential, DCm; a key para-
meter of mitochondrial bioenergetics. We previously adapted
this model and calibrated it so that its bioenergetic state
variables (Table 1) resembled mitochondrial bioenergetics in
HeLa cervical cancer cells.17 As input, the model assumed that
the mitochondrial tricarboxylic acid (TCA) cycle generated
NADH/NAD disequilibrium (Fig. 2, component 1). This
disequilibrium established a redox flux that drove electron
transfer and proton flux through respiratory complexes I, III
and IV (components 2, 3, 4). The proton gradient then coupled
to ATP production (component 5), adenosine nucleotide
transferase (component 6) and ionic fluxes (components
7–10). Cytosolic ATP turnover (component 11) was also
modelled so that this component, together with mitochondrial
ATP production, established a constant ratio of cytosolic
ATP : ADP. This ratio was set to 100 : 1 for cells under energy
saturation or 3 : 1 for cells with high ATP consumption whose
mitochondria need to produce ATP. The bioenergetic state
variables and their changes over time, the bioenergetic fluxes
that mediate these changes, the model parameters, the constants
and ion concentrations, and the biophysical constraints are
given in Tables 1–5, respectively.
To extract regulation principles for intact and impaired
mitochondria we followed two parameter variation approaches
where we aimed to identify regulatory components of mito-
chondrial bioenergetics (see the Materials and methods section
for details). In the first approach, we utilised single parameter
variation to identify model components most influential in
regulating bioenergetic state variables. In the second approach,
Fig. 2 The bioenergetic model, model components and model parameters. Illustration of the model used to study mitochondrial bioenergetics.
The model incorporated components of the cytosol, the mitochondrial inter-membrane space (IMS) and the mitochondrial matrix. Model
components are denoted with Arabic numbers and associated to bioenergetic fluxes in Table 2: (1) input flux from the TCA cycle (see Materials and
methods); (2)–(4) respiratory complexes I, III and IV, respectively; (5) ATP synthase; (6) adenosine nucleotide transferase (ANT); (7) proton leaks;
(8) outer membrane ATP/ADP and phosphate (Pi) passive transporters; (9) proton (H+)/phosphate co-transport; (10) potassium (K+)/proton
antiport; (11) cytosolic ATP processes consisting of cytosolic ATP production and consumption. Parameters associated with model components
are listed below the component and denoted by hash marks (‘#’) according to Table 3. Parameters that influence two components are written below
these components. The influence of parameters on model components is defined in Table 3. Grey regular/black italic text refers to model
parameters that increase/decrease the activity of the associated component(s). When one parameter influenced two model components, the
influence was in the same direction.
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we used a new method (parameter cluster analysis) to identify
how model components cooperate in (primarily) independent
clusters to influence the entire bioenergetic state. In both
approaches we checked whether variation of a certain parameter
or combination of parameters severely changed bioenergetic state
variables, such as the mitochondrial membrane potential (DCm),
and analysed these changes in different scenarios (high/low ATP,
intact or impairedmitochondria). If parameter variations changed
the model output, we concluded that model components or
combinations of components associated with these parameters
were decisive regulators of bioenergetics under these conditions.
Respiratory complex I as a driver for establishing DWm in intact
mitochondria
We first analysed HeLa cells with intact mitochondria in two
states; cells where cytosolic ATP consumption was low (cytosolic
ATP : ADP ratio assumed as 100 : 1, denoted as state-4 mito-
chondria), and cells with high ATP consumption (ATP : ADP
ratio assumed as 100 : 1, denoted as state-3 mitochondria) where
mitochondria need to replenish ATP.2,9 To study the influence of
parameter variation on DCm in both cases, we varied each
parameter independently by a 10- or 5-fold increase or decrease.
Varying parameters in the state-4 scenario, we found that
changes in total NADH concentration (parameter #1 in
Table 3, hash marks ‘#’ refer to parameters in Table 3 in
further), total ubiquinone concentration (#3), complex I activity
(#9), proton leak activity (#21), and the kinetic constant that
defines the amount of cytosolic ATP consumption (#16)
exercised the most significant influence on the mitochondrial
membrane potential, DCm (Fig. 3A). Of note, the three most
influential parameters were either metabolites associated with
respiratory complex I or parameters that determined its
enzymatic activity (Table 2, component 2). Since neither
complex III nor complex IV activity, nor cytochrome-c (cyt-c)
levels (the metabolite that transfers electrons between these
complexes) were found to influence DCm, we concluded that
complex I was the major component within the respiratory
chain that regulated DCm in state-4 mitochondria. These results
were further validated when we identified parameters associated
with complex I, but not complex III or IV as being essential for
regulating respiratory flux and the protomotive force in state-4
mitochondria (Fig. S1(A) and S2(A), ESIw).
The same decisive role for complex I-associated parameters
was found when cells were assumed to have high ATP con-
sumption and mitochondrial ATP production was only able to
establish a lower ATP : ADP ratio of 3 : 1 (75%ATP) (state-3
respiration, Fig. 3B). In this scenario, however, adenosine
nucleotide transferase (ANT, #19, as provider of mitochondrial
ADP) replaced proton leak activity as a critical driver of DCm
regulation. Several other interesting findings were obtained from
studying this state-3 scenario. Firstly, we found that, while ANT
had a decisive role in establishing DCm, the influence of ATP
synthase activity was much smaller. Consistent with these
observations, ANT activity, but not the activity of the ATP
synthase enzyme, regulated ATP synthase flux (Fig. S3, ESIw).
These findings portray ATP synthase as a component that is
driven by ANT (Fig. S4 and ESIw for a discussion of ATP
synthase as a ‘‘passive component’’). Secondly as shown in
Fig. 3B, DCm was quite robust against changes in the amount
of cytosolic ATP consumption in state-3 mitochondria. This
robustness is in agreement with experimental evidence demon-
strating that even changes from state-3 to state-4 only modestly
influence DCm (Nicholls and Budd, 2000) and is also in agreement
with the notion that DCm, as a key regulator of ionic homeostasis,
is robust against physiological changes in ATP consumption.
Finally, as an important model validation, our model was
stable to mild changes in the input parameters (#5–#8) in
state-3 and state-4 mitochondria (Fig. 3A and B). This is
consistent with the design decision to assume the TCA cycle
as non rate-limiting; a decision made to confine our analysis to
the study of the electron transport chain and its regulators (see
Fig. 2).
Regulation of DWm in impaired mitochondria
Impaired mitochondrial function is a hallmark of several
diseases such as cancer or Parkinson’s disease and a condition
often induced by chemotherapeutic treatment.8,10,40 Likewise,
hypoxia, which is present in many cancers, causes mitochondrial
Table 4 Constants and ion concentrations for the fluxes in Table 1
Symbol Description Value Unit
F Faraday constant 0.096484 kJ1 mol1 mV1
T Absolute temperature 310.15 (37) K (1C)
R Universal gas constant 8314  106 kJ1 mol1 K1
nA Protons pumped in by ATP Synthase 3
a Unitless
Mgtot Total cytosolic concentration of Mg
2+ 20b mM
Pitot Total cytosolic concentration of phosphate 20
b mM
Ktot Ionic conc. of potassium in the cytosol 120
b mM
pHc Cytosolic pH 7.4 Unitless
dGC1o Gibbs energy for complex I/II 69.37a kJ mol1
dGC3o Gibbs energy for complex III 32.53a kJ mol1
dGC4o Gibbs energy for complex IV 122.94a kJ mol1
dGF1o Gibbs energy for ATP synthase 36.03
a kJ mol1
O2,x Oxygen concentration matrix 2.6  105a M
Wx Volume fraction matrix/total mito 0.9
a Unitless
Wi Volume fraction IMS/total mito 0.1
a Unitless
Wc Volume fraction cytosol/mitochondria 20
c Unitless
a Constants and ion concentrations used in the model and taken from ref. 21. b Constants and ion concentrations used in the model and taken
from ref. 2. c Constants and ion concentrations used in the model and taken from ref. 29.
This journal is c The Royal Society of Chemistry 2012 Mol. BioSyst., 2012, 8, 828–842 835
impairment due to the lack of adequate oxygen levels. We were
therefore interested in applying our single parameter variation
approach to the study of changes in cellular bioenergetics before
and after mitochondrial impairment. Mitochondrial bioenergetics
during hypoxia has previously been investigated.41 We focussed
here on mitochondrial impairment in HeLa cells due to depletion
of mitochondrial cytochrome-c. Cyt-c release and its subsequent
depletion from the mitochondrial inter-membrane space are
induced by chemotherapeutic drugs and an understanding of
the bioenergetic consequences of cyt-c depletion is important to
obtain better insights into the mechanisms of chemoresistance
and clinical relapse.
We assumed two cases of mitochondria depleted of cyt-c
due to chemotherapeutic drugs. In the first case we assumed
0.5% remnant cyt-c available for respiration, mimicking complete
cyt-c release and re-equilibration of cyt-c levels in all compart-
ments. In the second case we modelled 5% remnant cyt-c,
assuming incomplete cyt-c release or a high volume fraction of
mitochondria in the cell (see Materials and methods). We
assumed state-3 conditions with the same ATP consumption
as before (ATP : ADP = 3 : 1). However, impairment of
mitochondrial ATP production due to cyt-c depletion (while
maintaining the same cytosolic ATP consumption as in the
state-3 scenario of Fig. 3B) led to lower levels of ATP (67%
and 70%, respectively). In both scenarios, parameters asso-
ciated with complex III activity (#10, #11) significantly influ-
enced DCm while complex I (#9) and complex IV (#13) activity
were less important (Fig. 4A and B). This indicates that
complex III is the major bottleneck in the respiratory chain
when cyt-c is depleted. As the only striking difference between
both scenarios, our results suggest that in the case of higher
cyt-c depletion (to 0.5% remnant levels), proton leak activity
(#21) exercised the most influence on DCm. This is consistent
with the assumption that respiration, and therefore proton
extrusion, is very low in such a case and any proton loss due
to proton leaks severely impacts the proton gradient, and
therefore DCm. In contrast, ANT activity (#19) was a more
decisive regulator of DCm when cyt-c depletion was more
modest (5%) suggesting that ATP production (with ANT as
its major driver, see above) is still present in this case and
influences DCm by proton consumption.
The bioenergetic state of intact, ATP-producing mitochondria is
regulated by three parameter clusters
In the previous paragraphs, we demonstrated that by studying
variations of ODE model parameters we can obtain regulatory
principles in healthy (state-3 and state-4) and impaired (state-3
only) mitochondria. We next focussed on the entire set of
bioenergetic state variables (Table 1), which we denoted as the
‘bioenergetic state’ as defined in the Materials and methods
section. We investigated how this state is regulated by the
interplay of several ODE model components such as the
activities of respiration complexes, the levels of respiration
metabolites, and ATP production and consumption.
We therefore performed a pair-wise variation of model
parameters and subsequently carried out a principal component
analysis to identify what parameter combinations (and therefore
ODE model components) act together to most significantly
influence the bioenergetic state. We then focussed on the three
parameter combinations (denoted as parameter clusters in
further) that exercised the most significant influence (Fig. 5A).
For further insight, parameters were grouped depending on
whether they originated from an ODE component that
describes (1) respiratory complexes and metabolites, (2) ATP
consumption, (3) ATP production or (4) other components of
the model (Fig. 5B). The method is described as ‘parameter
cluster analysis’ in the Materials and methods section.
This procedure allowed us to obtain a more abstract view of
mitochondrial bioenergetics as a set of coherent, sufficiently
separate, yet interacting entities. A similar way of portraying
mitochondrial bioenergetics has been provided by top-down
control analysis, assuming that abstract metabolic blocks,
Table 5 Biophysical constraints for fluxes in Table 1: biophysical
constraints that result from moiety or chemical conservation as used in
the model. Indices x, i and c of metabolites and chemical compounds
indicate mitochondrial matrix, inter-membrane space and cytosol,
respectively. Indices mx, mi and mc indicate magnesium bound ATP
and ADP while mf, mi and mc indicate free ATP and ADP in the
mitochondrial matrix, inter-membrane space and cytosol, respectively.
The index tot refers to the total moiety of a metabolite, while red and
ox indicate reduced and oxidised from of cyt-c
Moiety conservation
NADx (NADi) = NADtot  NADHx (NADHi)
Qx (Qi) = Qtot  QH2,x (QH2,i)
cytCox = cytCtot  cytCred
Conservation of Mg-bound ADP/ATP
ATPfx = ATPx  ATPmx
ADPfx = ADPx  ADPmx
ATPfi = ATPi  ATPmi
ADPfi = ADPi  ADPmi
ADPmc =
1
2
[(KDD + ADPc + Mgtot)
 {(KDD + ADPc + Mgtot)2
 4(ADPt  ADPc)}1/2]
ADPfc = ADPc  ADPmc
Mgc = Mgtot  ADPm
Gibbs energies of complexes
dGH = FDCm + RTLn (Hi/Hx)
dGC1op = dGC1o  RTLn (Hx/10–7)
dGC3op = dGC3o + 2RTLn (Hx/10
–7)
dGC4op = dGC4o  2RTLn (Hx/10–7)
dGF1op = dGF1o  RTLn (Hx/107)
Gibbs energies synthase
dGH = FDCm + RTLn (Hi/Hx)
dGC1op = dGC1o  RTLn (Hx/107)
dGC3op = dGC3o + 2RTLn (Hx/10
7)
dGC4op = dGC4o  2RTLn (Hx/107)
dGF1op = dGF1o  RTLn (Hx/107)
Phosphate–hydrogen binding
H2PIi = PiiHi/(Hi + kdHPi)
H2PIx = PixHx/(Hx + kdHPi)
Parameter for ANT
DCx = 0.65DCm
DCi = +0.35DCm
Values for cyt-c after release
CytCrelease = cytCtot/200 (0.5%)
= cytCtot/20 (5%)
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interacting via key intermediaries, control the bioenergetic
state.12–15 These metabolic blocks and intermediaries are
biologically motivated ad hoc assumptions, however, and it is
desirable to justify these assumptions from a more mechanistic
point of view. We therefore investigated whether the para-
meter clusters identified by our bottom-up approach were
in agreement with the metabolic blocks and key inter-
mediaries from top-down control analysis, and whether these
clusters were maintained when ATP levels were significantly
changed.
As seen in Fig. 5, three parameter clusters exercised 87%
control over the bioenergetic state variability for intact,
ATP-producing (state-3) mitochondria (ATP : ADP = 3 : 1).
Cluster 1 was responsible for 60% of this regulation. Besides a
small contribution from the adenosine nucleotide transferase
(ANT) activity parameter (#19), this cluster primarily included
contributions from respiratory complexes I and III (#9, #10, #11)
and their metabolites (NADH, cyt-c, ubiquinone; #1, #2, #3).
Due to this high contribution from respiration-associated
model components (90%, see the pie chart in Fig. 5(B)), we
denoted cluster 1 as the ‘‘respiration’’ cluster. Of note, this
cluster was similar to the metabolic block ‘oxidation subsystem’
used in the top-down control analysis literature.12,14 Cluster 2
accounted for 17% of the regulation. Parameters describing
cytosolic ATP consumption accounted for 65% of this cluster
(Fig. 5B) while parameters related to mitochondrial ATP
production such as total adenosine phosphate levels (#4), and
ANT activity (#19) accounted for a further 30%. We therefore
denoted cluster 2 as the ‘‘ATP production/consumption’’ cluster.
It can be compared to a combination of the two metabolic
blocks ‘phosphorylation subsystem’ and ‘ATP consumption’
used in top-down control analyses. Cluster 3 accounted for
10% of the regulation and included important parameters of
clusters 1 and 2. We denoted cluster 3 the ‘‘respiration–ATP
production coupler’’ cluster. This cluster did not resemble
a metabolic block from top-down control analyses. Rather,
it coupled the metabolic blocks ‘oxidation subsystem’
and ‘phosphorylation subsystem’ and can be viewed as a
key intermediary within the context of top-down control
analyses.
Bioenergetic clusters in intact mitochondria under energy
saturation
Some top-down control analyses assume metabolic blocks as
static over a broad range of bioenergetic scenarios which is
Fig. 3 Drivers of the mitochondrial membrane potential (DCm) in resting and ATP-producing mitochondria. Single parameter variation of model
parameters was performed as described and the influence on the mitochondrial membrane potential, DCm, is given for (A) resting (state-4,
ATP : ADP = 100 : 1) and (B) ATP-producing (state-3, ATP : ADP= 3 : 1) mitochondria. Dark blue, light blue, green, orange and brown bars
refer to a tenfold decrease, fivefold decrease, reference value, fivefold increase and tenfold increase of model parameters, respectively. Parameters
are ranked according to their influence on DCm with lowest rank indicating highest influence. In both situations, complex I was identified as the
most important respiratory complex in determining DCm. This is indicated by the low ranking of the parameter describing complex I activity (#9)
and parameters describing the concentration of its metabolites (NADH (#1), ubiquinone (#3)). Hash marks (‘#’) denote parameters according to
Table 3. Further results are discussed in the text.
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regarded as an important limitation in their applicability.42,43
We therefore investigated whether the same parameter clusters
were present when studying mitochondria under energy
saturation. In particular, we were interested in whether a similar
coupling pattern between respiration and ATP production, as in
Fig. 5, was present when intact mitochondria under energy
saturation were considered. Thus, we repeated our parameter
cluster analysis for intact mitochondria in state-4 (ATP : ADP=
100 : 1), where very little ATP production is assumed to occur.
These energy conditions are equivalent to those in mitochondria
of HeLa cells in full nutrient medium.26
As before, three major clusters were identified that exercised
85% control over the bioenergetic state (Fig. 6A). Cluster 1
was retained as an almost wholly ‘‘respiration’’ cluster with
major contributions from respiratory complex metabolites
(#1–3) and respiratory complex parameters (#9–12). Clusters
2 and 3, however, no longer clearly separated into ‘‘ATP
production/consumption’’ and ‘‘respiration–ATP-production
coupler’’, as cluster 2 now also had a significant, 25% influence
from parameters associated with metabolites or respiratory
complexes. The lack of a separate cluster that described ATP
production and consumption may be due to the fact that in HeLa
cells with high ATP levels, ATP consumption is low, the turnover
between ATP production and consumption is modest and
therefore the contribution to the regulation of bioenergetics
is low. Since an independent ATP production cluster was not
identified, the assumption of a model where an independent
respiration cluster interacts with an independent ATP production
cluster cannot be assumed in the case of intact, energy saturated
mitochondria (Fig. 6B).
Different parameter clustering in impaired mitochondria
Finally, we investigated the regulation of the bioenergetic state
for impaired mitochondria after cyt-c release to 5% remnant
cyt-c. We assumed state-3 conditions with the same cytosolic
ATP consumption as before which, as mitochondrial ATP
production was impaired due to depleted cyt-c, led to cytosolic
ATP levels of 67% (not shown in figure). Similar to intact
mitochondria, three parameter clusters exercised significant
control (77%) over the bioenergetic state (Fig. 7A). Impor-
tantly, however, all three major clusters were influenced
Fig. 4 Single parameter variation analysis subsequent to cytochrome-c release. Single parameter variation of model parameters was performed as
described in the case of complete (A) and incomplete (B) cytochrome-c (cyt-c) release (0.5% or 5% remnant cyt-c, respectively). Hash marks (‘#’)
denote parameters according to Table 3. The influence on the mitochondrial membrane potential, DCm, was evaluated and parameters were ranked
according to their influence. Respiratory complex III activity (#10) and parameters (#11, #12) and total cyt-c concentration (#2) were major
regulators of DCm, indicating a shift from respiratory complex I to respiratory complex III as a major regulator of respiration and DCm following
cyt-c release. Dark blue, light blue, green, orange and brown bars refer to a tenfold decrease, fivefold decrease, reference value, fivefold increase
and tenfold increase of model parameters, respectively. Further results are discussed in the text.
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by distinct model parameters suggesting that each cluster
regulated the bioenergetic state independently from the others.
In addition, two major clusters were influenced by respiratory
components and metabolites (Fig. 7B). The first cluster had
50% influence on the bioenergetic state and included mostly
complex III activity and complex III associated metabolites,
consistent with the decisive role of complex III after cyt-c
release. Strikingly, while complex I activity did not have any
influence on any of the three clusters, its driving metabolite
(NADH) almost completely influenced cluster 2 (11% influence
on the bioenergetic state). Finally, cluster 3 consisted of ATP
production and consumption and this cluster exercised 16%
influence on the bioenergetic state. In conclusion, these results
indicate that complex I activity is uncoupled from the activity
of the other respiratory complexes and respiration is largely
uncoupled from ATP production/consumption, suggesting
a lack of interplay between bioenergetic components after
cyt-c release.
Discussion
In this study, we have devised an approach to extract control
principles of mitochondrial and cellular bioenergetics from
mechanistically detailed, ODE based models by analysing how
bioenergetic state variables (Table 1) changed with model
parameter (Table 3) variation. Studying intact mitochondria
(ATP-producing and non-ATP-producing) by varying model
parameters independently from each other, our model identified
respiratory complex I and its metabolites, NAD/NADH and
ubiquinone, as key regulators of DCm. Respiratory complexes
III and IV did not show any detectable influence on DCm
in this scenario, even when their activity was increased or
Fig. 5 The bioenergetic state of cells with intact, ATP producing mitochondria (ATP : ADP = 3 : 1, state-3) is regulated by three parameter
clusters that resemble clusters assumed by top-down control analyses. Results from parameter cluster analysis as described in the text for HeLa
cells with intact mitochondria and an ATP : ADP ratio of 3 : 1 (state 3). Model parameters are indicated by hash mark numbers according to
Table 3. A principal component analysis and subsequent parameter grouping were performed. (A) Principal component analysis identified three
principal components that exercised 87% control over the bioenergetic state. The colour bar indicates the relative contribution of each parameter
to the respective principal component (parameter loadings). Parameters contributing significantly to each principal component (loading > 0.2) are
outlined in black. The total percentage influence of these outlined parameters on the respective principal component is given. (B) Parameters were
assigned to groups as indicated by colour coding ‘Respiratory complex metabolites and parameters’ (blue), ‘ATP consumption’ (red), ‘ATP
production’ (orange) and ‘Input and proton leaks and others’ (brown). For each principal component in (A) the collective influence of each
parameter group is given in the pie chart. In this way categorised principal components were denoted as clusters. Respiratory complex metabolites
and parameters primarily regulated cluster 1 (‘‘respiration’’ cluster), parameters influencing ATP production and consumption primarily regulated
cluster 2 (‘‘ATP-production/consumption’’ cluster), and a mixture of ‘‘respiratory complex metabolites and parameters’’ and ‘‘ATP production/
consumption’’ regulated cluster 3 (‘‘respiration–ATP coupler’’ cluster).
This journal is c The Royal Society of Chemistry 2012 Mol. BioSyst., 2012, 8, 828–842 839
decreased ten-fold. This suggests that complex I is the most
critical regulator within the mitochondrial electron transport
chain in intact mitochondria. Indeed, complex I has been
identified as rate-limiting for respiration in primary neuron
synaptosomes,44 and complex I inhibition led to more severe
respiration impairment than complex III inhibition in primary
neurons.45–48 Due to this rate-limiting action, respiratory
complex I deregulation is a hallmark of various pathologies.
To this end, post-mortem analysis of the substantia nigra from
patients suffering from Parkinson’s disease showed complex I
impairment in 25–30% of the patients.10 Likewise, the K-Ras
oncoprotein that is mutated in 50% of all colorectal carcinomas
was found to lead to complex I impairment and reduction of
mitochondrial respiration.40 Reduced mitochondrial respiration
in favour of elevated glycolysis is a well known characteristic of
many cancers.
In impaired mitochondria depleted of cyt-c, however, our
model predicted complex III activity as rate-limiting for respira-
tion. This is consistent with a previous study by our group49
where complex III was identified as the major site of reactive
oxygen species (ROS) production (as a measure of respiration
impairment) in hippocampal neurons subsequent to cyt-c
release.
Lower oxygen levels may also work synergistically with a
more modest impairment of complex III activity, and lead to a
similar rate limiting role for complex III.41 Hypoxic conditions
are typical for many cancers while complex III impairment is
present after chemotherapeutically induced cyt-c release.28 It is
therefore reasonable to assume that cancer cells that survive
chemotherapeutic treatment are both low in oxygen and have
impaired complex III. They may therefore be critically sensitive
to further changes in complex III activity.
Top-down metabolic control analysis (MCA) is used to
study cellular bioenergetics by defining metabolic blocks
linked by key intermediaries.12,50 Here, we have developed a
complementary, bottom-up approach to study how meta-
bolites, ions and fluxes influence mitochondrial bioenergetics.
As output, our method predicted how model parameters act in
Fig. 6 The bioenergetic state in cells with intact, resting state mitochondria (ATP : ADP= 100 : 1, state-4) does not lead to a decoupling of ATP
production in a separate cluster. Results from parameter cluster analysis as described in the text for HeLa cells with intact, resting mitochondria
and an ATP : ADP ratio of 100 : 1 (state 4). Model parameters are indicated by hash mark numbers according to Table 3. As described for Fig. 5,
a principal component analysis was performed (A) and parameters were assigned to groups (B). Three parameter clusters exercised 85% control
over the bioenergetic state. As above (Fig. 5), cluster 1 was primarily composed of mitochondrial respiration parameters and cluster 3 coupled
mitochondrial respiration to mitochondrial ATP production. However, mitochondrial and cytosolic ATP processes were not clearly decoupled
from mitochondrial respiration in cluster 2.
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combinations (denoted as clusters) to perturb the bio-
energetic state. Assuming intact, ATP-producing mitochondria
(ATP : ADP = 3 : 1), we found three parameter clusters that
controlled 89% of the bioenergetic state. These clusters—
‘‘respiration’’, ‘‘ATP production/consumption’’ and ‘‘respiration–
ATP-production coupler’’—can be associated to metabolic
blocks or coupling components of metabolic blocks assumed
by MCA. The identified ‘‘respiration cluster’’ (cluster 1) is
equivalent to the MCA component ‘respiration subsystem’,
while the identified ‘‘respiration–ATP-production coupler’’
(cluster 3) is assumed to be a coupling component (‘key
intermediary’ in an MCA context) between respiration and
mitochondrial ATP production. Of note, cluster 2 described a
composition of two MCA components, mitochondrial ATP
production and cytosolic ATP consumption. The fact that our
approach predicted two MCA components, ATP production
and consumption, within one cluster (intra-cluster coupling)
while ATP production and respiration coupled via a separate
cluster (inter-cluster coupling) suggests that ATP production
couples tighter to ATP consumption (via ATP levels) than to
respiration (via the protomotive force). This may, however, be
reflected in the structure of the analysed ODE model, where
we assumed a simplistic process of cytosolic ATP consumption
that is only dependent on ATP levels. In contrast, coupling of
ATP production to respiration via the protomotive force was
modelled in a more complex way (where all respiratory complexes
and proton leaks influenced the protomotive force).
Importantly, the composition of all three clusters changed when
ATP was close to 100% (ATP : ADP = 100 : 1). Moreover,
when mitochondria were depleted of cytochrome-c (cyt-c) no
coupling of the major clusters was observed. In this instance,
ATP production only poorly coupled with respiration (10%
contribution to first cluster). In addition, two separate respira-
tory clusters were identified in cyt-c depleted mitochondria;
Fig. 7 The bioenergetic state in impaired mitochondria subsequent to cyt-c release. Results from parameter cluster analysis as described in Fig. 5,
consisting of a principal component analysis (A) and parameter grouping (B) for impaired mitochondria following cyt-c release (5% remnant cyt-c
and 70% ATP (ATP : ADP less than 3 : 1 due to respiration impairment)). Parameters are indexed by hash mark numbers according to Table 3
and grouped as described in Fig. 5B. Although three parameter clusters exercised 77% control over the bioenergetic state, parameter clustering
changed in comparison to intact mitochondria (Fig. 5). Cluster 1 remained primarily a respiration cluster, yet did not include total NADH levels
(#1). In turn, cluster 2 was mainly driven by NADH levels (95% of cluster) and to a minor extent by total ubiquinone levels (3%). Cluster 3
described mitochondrial ATP production and cytosolic ATP consumption processes. Strikingly, negligible coupling of parameter clusters was
observed.
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one with a major influence on the bioenergetic state, driven by
complex III parameters, and one with a minor influence on the
bioenergetic state, driven by the complex I metabolite NADH.
In summary, these results suggest that in top-down control
analyses, static metabolic blocks should not be assumed
during significant ATP level changes or in situations where
mitochondria change from physiological to pathological
conditions such as during cyt-c release.
Models that integrate metabolism and signalling are essential to
understanding how metabolic fluxes are redirected by signalling
events or by oncoproteins, and how tumour suppression and cell
death machinery prevent cells from metabolic and oncogenic
transformations.3,4,51 Oncogenic alterations in metabolism,
however, are often the result of several oncoproteins or
deregulations of metabolic enzymes.6,7,52,53 Consequently,
the interlocking network of metabolism and signalling is large
and intricate. Given the high degree of unknown kinetic
parameters and protein concentrations needed for model
construction, analyses with mechanistic ODE models alone
are impractical. A more abstract method, therefore, is needed
to elucidate the principles of how aberrant signalling alters
metabolism. While top-down control analysis provides an
excellent level of abstraction, we have shown that the assumption
of static metabolic blocks may not always be justified. Moreover,
while top-down control analysis is well suited to studying
quasi-static metabolic fluxes, cellular signal transduction such
as activation of cell death proteases has been shown to be
highly dynamic.54,55 Our method described herein combines
the mechanistic details of ODE based models with the
potential to extract higher level metabolic regulation principles.
It is therefore well suited to analysing the interplay of
metabolic, oncogenic and cell death signalling in larger scale
networks. In conclusion, our study advocates for this bottom-up
analysis as an important complement to top-down control
analyses when studying larger networks describing the interplay
of signalling and metabolism, and provides a missing link
between high-level top-down analyses and mechanistically
detailed approaches.
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